isaac ciechanover atara biotherapeutics inc profile  biography  bloomberg feedback isaac ciechanover chairmanpresceocofounder atara biotherapeutics inc career history president pinta biotherapeutics inc present chairmanpresceocofounder atara biotherapeutics inc present presidentceocofounder atara biotherapeutics inc unknown partner kleiner perkins caufield  byers llc unknown exec dirbusiness dev celgene corp former headglobal teams array biopharma inc former headglobal teams agios pharmaceuticals inc former headglobal teams merck kgaa former show more website wwwatarabiocom corporate information address  gateway blvd suite  s san francisco ca  united states phone  fax  web url wwwatarabiocom from the web personal information education harvard business school mba weill cornell medical college md university of cambridge masters degree stanford university bachelors degree physiology show more memberships board memberships atara biotherapeutics inc chairman present atara biotherapeutics inc board member unknown sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data isaac e ciechanover  new york ny  intelius sign in we found isaac e ciechanover in new york ny isaac e ciechanover intelius found that isaac e ciechanover is a male between  and  years old from new york ny we have connected them to  addresses  phones and  relatives or associates get report now age isaac e ciechanover is in his s isaac has lived in new york ny palo alto ca santa cruz ca isaacs relatives allison ciechanover atara ciechanover dasna ciechanover tamar ciechanover isaac e ciechanover zodiac signpisces gendermale professional status executive director in the business development at kleiner perkins caufield  byers get report now want to know more about isaac get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about isaac or use our people search engine to find others get background check on isaac e ciechanover get a criminal check on isaac e ciechanover get a public record report on isaac e ciechanover get a people search report on isaac e ciechanover isaac e ciechanovers contact information known cities lived in find out where isaac e ciechanover has lived as well as isaac e ciechanovers phone numbers and email addresses isaac e ciechanover has lived in  states new york address for isaac e ciechanover  c a new york ny has lived in new york ny palo alto ca get full address report phone numbers associated with isaac e ciechanover    brisbane ca    brisbane ca    new york ny get full phone report email addresses associated with isaac e ciechanover ircom ircom ircom get email report isaac e ciechanovers professional information information regarding isaac e ciechanovers professional history find out previous places isaac e ciechanover has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act isaac e ciechanover has worked at  places company kleiner perkins caufield  byers title executive director in the business development company atara biotherapeutics inc title president and chief executive officer isaac e ciechanovers experience title executive director in the business development company kleiner perkins caufield  byers job details company size  mil to less than  mil  employee range  to less than  title president and chief executive officer company atara biotherapeutics inc job details company size  mil to less than  mil  employee range less than  atara biotherapeutics inc is a biopharmaceutical company focused on developing meaningful therapies for patients with unmet medical needs in diseases that have seen limited therapeutic innovation atara bios programs include molecularly targeted product candidates and tcell product candidates molecularly targeted product candidates include pinta  stm  and ata  these product candidates target myostatin and activin members of the tgfbeta family of proteins and have demonstrated the potential to have therapeutic benefit in a number of clinical indications tcell product candidates include ebvctl cmvctl and wtctl additional professional information on isaac e ciechanover see isaac e ciechanovers linkedin profile isaac e ciechanovers social network and potential email matches find out potential social network profiles and potential email usernamed for isaac e ciechanover isaac e ciechanovers known social networks and potential email matches find all of isaac e ciechanovers social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches isaac ciechanover username matches isaacciechanover ciechanoverisaac isaacciechanover ciechanoverisaac isaacciechanover ciechanoverisaac isaacciechanover ciechanoverisaac iciechanover popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches i ciechanover intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here ciechanover isaac e  insider stock trading  openinsider sector all sectors group by sector aerospace agriculture automobile building business services chemical electrical energy fashion financial food  beverage fund healthcare household insurance machinery media metals mining other personal services real estate retail technology telecom transportation utility industry all industries group by industry insiders filings all purchases sales cik   address  gateway boulevard suite  south san francisco ca   results links secyahoogooglefinviztradingviewstockchartsstocktwitsdownload csv tc stat stk ins fil d w m q h y avg sretswins filing date t date ticker issuerinc sector indindustry owner ost rel title t tval price l qty oc own h ry ry rm rm rw rw rd rd fd fw fm fm fm fy  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceomdd  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceomdm  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosdmm  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceomdd  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmm  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceomdm  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceomdd  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceomdd  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceomdd  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmm  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceomdd  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmm  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceomdd  atraatara biotherapeutics incdehealthbioprdbiological products no diagciechanover isaac ecadoceosmi dderivative transaction in filing usually option exercise mmultiple transactions in filing earliest reported transaction date and weighted average transaction price aamended filing eerror detected in filing s  salesale of securities on an exchange or to another person s  saleoesale of securities on an exchange or to another person after option exercise f  taxpayment of exercise price or tax liability using portion of securities received from the company p  purchasepurchase of securities on an exchange or from another person return to top contact copyright   openinsidercom all rights reserved isaac e ciechanover md  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in isaac e ciechanover md president chief executive officer and chairman of the board at atara biotherapeutics inc view full profile are you isaac e ciechanover md claim your profile   sign up for equilar atlas and view isaac e ciechanover mds full profile with equilar atlas you can identify corporate executives in isaac e ciechanover mds network and community follow changes in isaac e ciechanover mds employment and moneyinmotion connect with isaac e ciechanover md through your network of contacts isaac e ciechanover mds executive work history current president chief executive officer and chairman of the board atara biotherapeutics inc past to view isaac e ciechanover mds complete executive work history sign up now age      isaac e ciechanover mds biography isaac e ciechanover md  has served as our president and chief executive officer and a member of the board since our founding in august  from april  to november  dr ciechanover was a partner at kleiner perkins caufield  byers a venture capital firm where he primarily focused on life sciences investing from  to march  he served in various capacities at celgene corporation a biopharmaceutical company most recently as executive director for business development dr ciechanover has also held business development and venture capital roles at pharmaceutical companies amylin pharmaceuticals and pfizer and ventur  read more isaac e ciechanover md  has served as our president and chief executive officer and a member of the board since our founding in august  from april  to november  dr ciechanover was a partner at kleiner perkins caufield  byers a venture capital firm where he primarily focused on life sciences investing from  to march  he served in various capacities at celgene corporation a biopharmaceutical company most recently as executive director for business development dr ciechanover has also held business development and venture capital roles at pharmaceutical companies amylin pharmaceuticals and pfizer and venture capital firm pequot ventures dr ciechanover received a ba from stanford university an mphil in epidemiology from cambridge university an md from weill cornell medical college and an mba from harvard business school we believe that dr ciechanovers extensive experience in the life sciences industry and in business development his role as our president and chief executive officer and his training as a physician provide him with the qualifications and skills to serve on our board source atara biotherapeutics inc on    sign up for equilar atlas and view isaac e ciechanover mds full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like isaac e ciechanover md more specifically youll be able to identify corporate executives in isaac e ciechanover mds network and community follow changes in isaac e ciechanover mds employment and moneyinmotion connect with isaac e ciechanover md through your network of conections view full profile   search for over  executive profiles bio example isaac e ciechanover md isaac e ciechanover mds connections  sign up now to view isaac e ciechanover mds  connections » eric l dobmeier chief operating officer seattle genetics inc joseph s lacob board member align technology inc margaret c whitman dir president and chief executive officer hewlett packard enterprise company eckard weber chairman of the board ocera therapeutics inc joel s marcus chairman of the board chief executive officer president and founder alexandria real estate equities gad soffer executive vice president and chief strategy officer atara biotherapeutics inc mitchall g clark chief regulatory and quality assurance officer atara biotherapeutics inc christopher haqq executive vice president research and development and chief scientific officer atara biotherapeutics inc matthew k fust board member atara biotherapeutics inc carol g gallagher lead independent director atara biotherapeutics inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   ﻿ isaac ciechanover sold  shares of atara biotherapeutics inc nasdaqatra – octafinance friday  july  menu featured news  years ago  alphabet inc nasdaqgoogl tests its ad technology on billboards to cushion itself against ad blocks  years ago  china margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisis  years ago  marc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and gold  years ago  carl icahn criticizes the fed feels bad for investors buying junk bonds  years ago  john burbank european qe can’t save the markets same as the us quantitative easing everything will be liquidated isaac ciechanover sold  shares of atara biotherapeutics inc nasdaqatra  by octastaff in insider news momentum equities share with your friendsyour nameyour emailrecipient emailenter a messagei read this article and found it very interesting thought it might be interesting for you the article is called isaac ciechanover sold  shares of atara biotherapeutics inc nasdaqatra and is was published by octafinancecom at httpwwwoctafinancecomisaacciechanoversoldsharesofatarabiotherapeuticsincnasdaqatracaptchasubmit isaac ciechanover insider sell transaction the chief executive officer of atara biotherapeutics inc nasdaqatra    isaac ciechanover has made a surprising deal in the firm that is having a total value  us dollars as announced in the washingtonbased security and exchange commission electronic document filed on august   isaac sold  shares at average stock price per share of  it seems he is very active lately as in the last  days he quietly sold additional  shares of the company worth  usd isaac ciechanover now has ownership of  million shares which are equivalent to exactly  of the californiabased company’s total market cap market capitalization is a measurement of business value based on share price and number of shares outstanding atara biotherapeutics inc stock rating sentiment and fundamentals three of the big league analysts responsible to analyzing the company’s share predict an earningspershare of  and a price to earnings ratio of nan for the reporting year  rating  sentimentpsychsignal socialsellanalysts ratingbuyhedge funds sentimentbuy stock fundamentalsearnings  fcf trendsellsectorindustry macrobullishvaluation models technical analysisst trendupmt trenduplt trendup octafinance ratingneutral  read how our stock ratings system works our experts have no choice but to rate the stock neutral despite isaac’s stock deal because of our backtested equities time momentum model which is displayed below in the last  days alone the atara biotherapeutics inc’s share price has climbed  and continues to smoothly trend up price chart of atara biotherapeutics nasdaqatra stock source rightedgesystems yahoo split  dividend adjusted data and octafinance interpretations hedge funds ownership data gathered from sec filings reveal that  institutional players owned shares of atara biotherapeutics inc octafinance tracked institutional players have traditionally had a low interest in this company and that was also the case in q  the institutional ownership was  of the stock’s outstanding shares ecor capital llc had the greatest investment with ownership of  shares as of q  for  of the fund’s portfolio seth klarman’s baupost group llc ma is another bullish institutional manager owning  million shares of the company or  of their stocks portfolio the stock is also  of the fund’s aum the new yorkbased fund bridger management llc have  of their stock portfolio invested in the stock for  shares further the californiabased fund redmile group llc revealed it had purchased a stake worth  of the fund’s stock portfolio in the company jacob gottlieb’s visium asset management lp was also a notable believer in the public company owning  shares atara biotherapeutics inc is  of the fund’s stock portfolio atara biotherapeutics nasdaqatra company profile atara biotherapeutics inc is a clinical stage biopharmaceutical company the company is focused on developing therapeutics for serious unmet medical needs with an initial focus on muscle wasting conditions and oncology the company’s lead product candidate pinta  is a peptibody that binds myostatin and inhibits its corresponding signal transduction thereby blocking the negative regulation of skeletal muscle growth pinta  is in a phase ii clinical trial the company’s second product candidate stm  which is in a phase i clinical study is a soluble actrb receptor that binds activin a the company has five additional product candidates ata  a humanized antibody targeting myostatin ata  a fully human antibody targeting activin a ata m a fully human antiactrab monoclonal antibody stm  a soluble actrb receptorigg fc fusion protein and a close analog of stm  and actrb a soluble actrb receptor that can be fused to an igg fc receptor company website atara biotherapeutics atara biotherapeutics inc was founded in delaware on  as of writing its market worth is  billion and it has  million shares outstanding now the company has  shareholders and the institutional ownership is  atara biotherapeutics inc has  employees the stock closed at  yesterday and it had average  days volume of  shares it is up from the  days average shares volume of  atara biotherapeutics inc has a w low of  and a one year high of  the current price is above the  days simple moving average atara biotherapeutics inc last issued its quarterly earnings data on  the company reported  eps for the quarter missing the consensus estimate of  by  the company had a revenue of for  and for  therefore the revenue was down  transaction pursuant to rule b plan adopted december  –   the price in column  is a weighted average sale price the prices actually received ranged from  to  the reporting person will provide to the issuer – any security holder of the issuer – or the sec staff – upon request – information regarding the number of shares sold at each price within the range  shares are held by the isaac e ciechanover and allison m ciechanover family trust dated  – of which the reporting person is a trustee  the price in column  is a weighted average sale price the prices actually received ranged from  to  the reporting person will provide to the issuer – any security holder of the issuer – or the sec staff – upon request – information regarding the number of shares sold at each price within the range  the price in column  is a weighted average sale price the prices actually received ranged from  to  the reporting person will provide to the issuer – any security holder of the issuer – or the sec staff – upon request – information regarding the number of shares sold at each price within the range  the price in column  is a weighted average sale price the prices actually received ranged from  to  the reporting person will provide to the issuer – any security holder of the issuer – or the sec staff – upon request – information regarding the number of shares sold at each price within the range  the price in column  is a weighted average sale price the prices actually received ranged from  to  the reporting person will provide to the issuer – any security holder of the issuer – or the sec staff – upon request – information regarding the number of shares sold at each price within the range  sheld are held by the ciechanover family grat – of which the reporting person is a trustee  sheld are held by the the ciechanover  grat – of which the reporting person is a trustee receive news  ratings via email  enter your email address below to receive a concise daily summary of the latest news and analysts ratings with marketbeatcoms free daily email newsletter tagged atara biotherapeutics  nasdaqatraisaac ciechanover daniel hendrix interface inc nasdaqtile’s insider sold  shares hanover insurance group inc nysethg senior vice president mark welzenbach unloaded  in stock free email newsletter enter your email address below to get the latest news and analysts ratings for your stocks with our free daily email newsletter hedge fund newstop  citadel advisors f holdings in q df dent  co inc just released its q  stock positionsmaverick capital top  holdings in q analyzing ken griffins citadel advisors stock holdings in q lone pine capital top  f positions in q guru newsfelix zulauf sees a stock market correction coming this rally sp  indexspinx will be shortlivedmarc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and goldjim grant the next thing might be helicopter money what to buy and where he sees investment opportunitieskyle bass bearish on emerging markets for at least  more years looking to short currenciesdavid tepper gets defensive is it time to get out of the stock market macro newschina margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisisare us – russian relations a zerosum gameus and russia have launched direct talks on the conflict in syriayuan drops as pboc cuts reference rate by most since devaluationcould the market crash like —put volume spike argues low is nearctas newsred rock just published report about the trend following landscape  how ctas’ performance must be analyzedhow to implement dual momentum for nonus investorsdo commodity trading advisors ctas really provide crisis alpha equity hedge and are long volatility isaac ciechanover president  ceo atara biotherapeutics timesjavascript is disabled market profiles login sign up login sign up   edit person isaac ciechanover president  ceo at atara biotherapeutics location san diego ca add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop isaac ciechanover president  ceo at atara biotherapeutics location san diego ca add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop dr isaac ciechanover is a physician investor and entrepreneur driven by a passion to improve the practice of medicine motivated by the belief that the majority of medical discoveries still lie ahead he has dedicated the past  years to working with entrepreneurs and life sciences organizations to advance medicine through innovation and technology he founded atara biotherapeutics in october  previously he was a partner in the life sciences practice at kleiner perkins caufield  byers earlier as celgene’s executive director in business development he spearheaded the company’s venture capital efforts and led licensing and ma activities with an aggregate value of more than  billion also at celgene he was global project leader for the company’s first clinicalstage biologic therapy isaac has also held business development and venture capital roles at amylin pharmaceuticals pequot ventures’ healthcare practice and pfizer  companies in career na related markets  colleagues na related investments alias na industry rd in biotech environmental and various industries no marketing product yet tags na topics of influence web site na careers achievements investments related people edit view all isaac ciechanovercareer  oct atara biotherapeutics president  ceo celgene executive director kleiner perkins caufield  byers partner competencies edit view all isaac ciechanovereducation  cambridge university mphil in epidemiology weill cornell medical college harvard business school stanford university psychology edit isaac ciechanoverachievements and recognitions add milestone no milestones has been recorded for isaac ciechanover edit isaac ciechanoverlinks add link no links has been recorded for isaac ciechanover isaac ciechanoverinvestmentsacquisitions no investments has been recorded for isaac ciechanover isaac ciechanoverinvestments representing others no investment reps has been recorded for isaac ciechanover isaac ciechanoverrelated people colleagues at atara biotherapeutics joe newell executive vice president and chief technical operations officer apr david carmel head of immunotherapy mar derrell porter senior vice president and global commercial head jul gad soffer chief operating officer mar view all peers  joseph m hogan president and ceo of align technology waleed hassanein president  ceo of transmedics laura brege president  chief executive officer of nodality peter maag president and ceo of caredx niamh pellegrini president  ceo of autonomic technologies jon p stonehouse president chief executive officer of biocryst pharmaceuticals view all isaac ciechanoverrecommended market profiles  life sciences kleiner perkins caufield  byers  or more employees  companies healthcare corporate venture deals    employees  companies isaac e ciechanover md executive profile  biography  bloomberg july    am et biotechnology company overview of atara biotherapeutics inc snapshotpeople  overviewboard memberscommittees executive profile isaac e ciechanover mdceo president  director atara biotherapeutics incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationshipsas of fiscal year  background dr isaac e ciechanover md has been the president and chief executive officer of atara biotherapeutics inc since august  dr ciechanover serves as the president of pinta biotherapeutics inc for more than  years dr ciechanover has worked with entrepreneurs and organizations to advance the practice of medicine through innovation and technology with both a medical and business background he bridges the gap between the scientific and business communities  he was an investment partner at kleiner perkins caufield  byers he joined kleiner perkins caufield  byers in april  and provided counsel and guidance to its network of life science entrepreneurs dr ciechanover was an associate at firstmark capital llc he served as the executive director of business development at celgene corporation dr ciechanover’s responsibilities included sourcing and execution and leading global teams for inlicensing and merger and acquisition activities for the research and development and commercial functions he was also the global project leader for celgene corporation’s first clinical stage biologic therapy and initiated and led its clinical venture investment and alliance management activities dr ciechanover managed business development and planning for amylin pharmaceuticals he also analyzed and vetted acquisition candidates at pfizer inc he serves as a director of atara biotherapeutics inc and pinta biotherapeutics inc dr ciechanover drove life sciences venture capital efforts for pequot ventures he began his career working as a venture capitalist in the healthcare practice of pequot ventures he has sourced a number of investments for pequot ventures and is a board observer at corventis crescendo elcelyx five prime and tesaro dr ciechanover is a contributor to the multiple myeloma research foundation and project smile he received an md from the weill cornell medical college an mba from the harvard business school an mphil in epidemiology from the university of cambridge and a ba in psychology from stanford universityread full background corporate headquarters  gateway boulevardsouth san francisco california united statesphone fax  board members memberships member of the board of the directors and presidentpinta biotherapeutics incpresentceo president  directoratara biotherapeutics inc education ba stanford universitymba harvard business schoolmd cornell universitymph university of cambridge other affiliations kleiner perkins caufield  byersfirstmark capital llcstanford universitycelgene corporationharvard business schoolcornell universityuniversity of cambridgepinta biotherapeutics inc annual compensation salarybonustotal annual compensation stocks options restricted stock awardsall other compensationexercisable optionsunexercisable optionstotal number of options total compensation total annual cash compensationtotal short term compensationother long term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact atara biotherapeutics inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close isaac ciechanover  atara biotherapeutics inc  zoominfocom ciechanover isaac e  sec form  insider trading screener  openinsider openinsider latest latest cluster buys latest insider trading all filings latest insider purchases latest insider purchases k latest officer purchases k latest ceocfo purchases k latest insider sales latest insider sales k latest officer sales k latest ceocfo sales k top top officer purchases today top officer purchases past week top officer purchases past month top insider purchases today top insider purchases past week top insider purchases past month top insider sales today top insider sales past week top insider sales past month by symbol officer purchases k today officer purchases k past week officer purchases k past month officer sales k today officer sales k past week officer sales k past month officer sales k today no optex officer sales k past week no optex officer sales k past month no optex insider purchases of penny stocks past month insider sales of penny stocks past month charts contact ciechanover isaac e  sec form  insider trading screenercik   address  gateway boulevard suite  south san francisco ca  general tickers insider sh price  lqdty m date filing date all dates custom latest day last  days last  week last  weeks last  month last  months last  months last  months last  year last  years last  years    trade date all dates custom latest day last  days last  week last  weeks last  month last  months last  months last  months last  year last  years last  years    filing delay n days ago transaction filing p  purchase s  sale a  grant d  sale to iss g  gift f  tax m  option ex x  option ex c  cnv deriv w  inherited no deriv multiple days traded k own chg  industry all sectors except funds agriculture forestry fish mining construction manufacturing transportation  utilities wholesale trade retail trade financial services closedend funds insider title   officer     cob     ceo     pres     coo     cfo     gc     vp   director    own   other group by filing company company totals num filings num insiders num officers traded k own chg  sort by filing date trade date ticker symbol trade value max results page clear realtime csv options alerts  results        tccntdwmms x filing date trade date ticker insider nameinsider title trade type  share price shares traded shares owned own chg value traded d ret w ret m ret m ret m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale dm  atraciechanover isaac eceos  saleoe m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale m  atraciechanover isaac eceos  sale realtime csv options alerts contact us aamended filing dderivative transaction in filing usually option exercise eerror detected in filing mmultiple transactions in filing earliest reported transaction date and weighted average transaction price s  salesale of securities on an exchange or to another persons  saleoesale of securities on an exchange or to another person after option exercisef  taxpayment of exercise price or tax liability using portion of securities received from the companyp  purchasepurchase of securities on an exchange or from another person return to top copyright   openinsidercom all rights reserved insider trading  ciechanover isaac e  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  ciechanover isaac e select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in goto page   next common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    directindirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view sale  pm atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector    indirectdirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing exercise  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view exercise  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view option award  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view exercise  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view gift  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   indirect view exercise  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view exercise  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view exercise  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view exercise  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view exercise  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view option award  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   indirect view option award  pm na atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view exercise  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view exercise  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view exercise  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view exercise  pm nana atara biotherapeutics inc atra ciechanover isaac echief executive officerdirector   direct view goto page   next   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement